Indication

Partial central diabetes insipidus

Partial central diabetes insipidus, also classified as partial arginine vasopressin deficiency, is an endocrine disorder of water homeostasis affecting children and adults. Read more about Partial central diabetes insipidus

52 drugs 38 manufacturers

Advertisement

Drugs that treat it

Common Partial central diabetes insipidus therapies.

Showing 28–36 of 52 drugs

Filter & compare in the drug finder →Opens the drug finder with Partial central diabetes insipidus preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Partial central diabetes insipidus.

Partial central diabetes insipidus, also classified as partial arginine vasopressin deficiency, is an endocrine disorder of water homeostasis affecting children and adults.

It is characterized by an incomplete deficiency in the hypothalamic synthesis, transport, or posterior pituitary secretion of antidiuretic hormone (arginine vasopressin), often arising from neurosurgery, head trauma, intracranial neoplasms, infiltrative diseases, or idiopathic causes.

Unlike complete forms, patients retain residual hormone secretion, allowing modest endogenous urinary concentration under osmotic stress.

Consequently, it clinically manifests as variable degrees of hypotonic polyuria, compensatory polydipsia, and an impaired renal ability to conserve free water, with a significant increase in urine osmolality following exogenous vasopressin administration.

Personalize your experience

Follow Partial central diabetes insipidus and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it